The consensus in literature suggests that a higher PD-L1 tumor proportion score (≥50%) and mutational burden is correlated with a positive smoking history, and that smokers show better overall response rates of ICI than nonsmokers [28,36]. The gene discussed is CD274; the disease is neoplasm.